These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4094191)

  • 21. Prevention by thioethers of the hepatotoxicity and covalent binding to macromolecules of N-hydroxy-2-acetylaminofluorene and its sulfate ester in rat liver in vivo and in vitro.
    van den Goorbergh JA; de Wit H; Tijdens RB; Mulder GJ; Meerman JH
    Carcinogenesis; 1987 Feb; 8(2):275-9. PubMed ID: 2433070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in rat liver N-hydroxy-2-acetylaminofluorene aryl sulfotransferase activity at early and late stages of hepatocarcinogenesis resulting from dietary administration of 2-acetylaminofluorene.
    Ringer DP; Norton TR; Cox B; Howell BA
    Cancer Lett; 1988 Jun; 40(3):247-55. PubMed ID: 3164251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of nucleophiles with the enzymatically-activated carcinogen, N-hydroxy-2-acetylaminofluorene, and with the model ester, N-acetoxy-2-acetylaminofluorene.
    Smith BA; Gutmann HR; Springfield JR
    Carcinogenesis; 1985 Feb; 6(2):271-7. PubMed ID: 3971491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute and chronic effects of pyrogen on mitochondrial monoamine oxidase (MAO) activity and respiratory activity in the rabbit liver (author's transl)].
    Nishio A; Kanoh S
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(5):301-6. PubMed ID: 7203272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic N-acetyltransferases: selective inactivation in vivo by a carcinogenic N-arylhydroxamic acid.
    Smith TJ; Hanna PE
    Biochem Pharmacol; 1988 Feb; 37(3):427-34. PubMed ID: 3257389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The essential role of microsomal deacetylase activity in the metabolic activation, DNA-(deoxyguanosin-8-yl)-2-aminofluorene adduct formation and initiation of liver tumors by N-hydroxy-2-acetylaminofluorene in the livers of infant male B6C3F1 mice.
    Lai CC; Miller EC; Miller JA; Liem A
    Carcinogenesis; 1988 Jul; 9(7):1295-302. PubMed ID: 3383346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of DNA adducts from N-acetoxy-2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in rat hemopoietic tissues in vivo.
    Vu VT; Grantham PH; Roller PP; Hankins WD; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1986 Jan; 46(1):233-8. PubMed ID: 3940194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teratogenicity in vitro of two deacetylated metabolites of N-hydroxy-2-acetylaminofluorene.
    Faustman-Watts EM; Greenaway JC; Namkung MJ; Fantel AG; Juchau MR
    Toxicol Appl Pharmacol; 1984 Oct; 76(1):161-71. PubMed ID: 6484986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by pentachlorophenol.
    Meerman JH; Beland FA; Mulder GJ
    Carcinogenesis; 1981; 2(5):413-6. PubMed ID: 7273322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The binding of N-hydroxy-2-acetylaminofluorene to DNA and repair of the adducts in primary rat hepatocyte cultures.
    Howard PC; Casciano DA; Beland FA; Shaddock JG
    Carcinogenesis; 1981; 2(2):97-102. PubMed ID: 6168407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between clastogenicity and promotion activity in liver carcinogenesis by N-hydroxy-2-acetylaminofluorene, N-hydroxy-4'-fluoro-4-acetylaminobiphenyl and N-hydroxy-4-acetylaminobiphenyl.
    van de Poll ML; van der Hulst DA; Tates AD; Meerman JH
    Carcinogenesis; 1990 Feb; 11(2):333-9. PubMed ID: 2302760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solvolysis and metabolic degradation, by rat liver, of the ultimate carcinogen, N-sulfonoxy-2-acetylaminofluorene.
    Smith BA; Springfield JR; Gutmann HR
    Mol Pharmacol; 1987 Apr; 31(4):438-45. PubMed ID: 3574289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene on the cellular levels of epoxide hydratase, cytochrome P-450b, and NADPH-cytochrome c (P-450) oxidoreductase messenger ribonucleic acids.
    Gonzalez FJ; Samore M; McQuiddy P; Kasper CB
    J Biol Chem; 1982 Sep; 257(18):11032-6. PubMed ID: 6809765
    [No Abstract]   [Full Text] [Related]  

  • 34. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes.
    Smith TJ; Hanna PE
    Carcinogenesis; 1986 May; 7(5):697-702. PubMed ID: 3486051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-hydroxy-2-acetylaminofluorene as effective inhibitor of aldehyde oxidase.
    Tatsumi K; Kitamura S
    Biochem Biophys Res Commun; 1986 Jul; 138(1):312-7. PubMed ID: 3741414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: strain and species differences.
    Graichen ME; Dent JG
    Carcinogenesis; 1984 Jan; 5(1):23-8. PubMed ID: 6690083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of kynurenine hydroxylase in developing rat brain.
    Battie C; Verity MA
    J Neurochem; 1981 Mar; 36(3):1308-10. PubMed ID: 6259288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial permeability transition is altered in early stages of carcinogenesis of 2-acetylaminofluorene.
    Klöhn PC; Bitsch A; Neumann HG
    Carcinogenesis; 1998 Jul; 19(7):1185-90. PubMed ID: 9683176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfation of N-hydroxy-2-acetylaminofluorene in normal and nodular liver from male Wistar rats.
    Blanck A; Wicksell L; Eriksson LC
    Toxicol Pathol; 1987; 15(1):103-5. PubMed ID: 3576071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irreversible inhibition of rat hepatic transacetylase activity by N-arylhydroxamic acids.
    Wick MJ; Jantan IB; Hanna PE
    Biochem Pharmacol; 1988 Apr; 37(7):1225-31. PubMed ID: 3355596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.